487 related articles for article (PubMed ID: 26374512)
1. An overview of pregnancy-related issues in patients with multiple sclerosis.
Pozzilli C; Pugliatti M;
Eur J Neurol; 2015 Oct; 22 Suppl 2():34-9. PubMed ID: 26374512
[TBL] [Abstract][Full Text] [Related]
2. Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
Berenguer-Ruiz L; Gimenez-Martinez J; Palazón-Bru A; Sempere AP
J Neurol; 2019 Oct; 266(10):2512-2517. PubMed ID: 31256279
[TBL] [Abstract][Full Text] [Related]
3. Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding.
Ferrero S; Esposito F; Pretta S; Ragni N
Expert Rev Neurother; 2006 Dec; 6(12):1823-31. PubMed ID: 17181429
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
Thiel S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
Mult Scler; 2016 May; 22(6):801-9. PubMed ID: 26920382
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and pregnancy.
Tsui A; Lee MA
Curr Opin Obstet Gynecol; 2011 Dec; 23(6):435-9. PubMed ID: 22011954
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and Family Planning in Multiple Sclerosis.
Langer-Gould AM
Continuum (Minneap Minn); 2019 Jun; 25(3):773-792. PubMed ID: 31162316
[TBL] [Abstract][Full Text] [Related]
7. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Fragoso YD; Boggild M; Macias-Islas MA; Carra A; Schaerer KD; Aguayo A; de Almeida SM; Alvarenga MP; Alvarenga RM; Alves-Leon SV; Arruda WO; Brooks JB; Comini-Frota ER; Ferreira ML; Finkelsztejn A; Finkelsztejn JM; de Freitas LD; Gallina AS; da Gama PD; Georgetto S; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Lourenco GA; Malfetano FR; Morales NM; Morales Rde R; Oliveira CL; Onaha P; Patroclo C; Ribeiro SB; Ribeiro TA; Salminen HJ; Santoro P; Seefeld M; Soares PV; Tarulla A; Vasconcelos CC
Clin Neurol Neurosurg; 2013 Feb; 115(2):154-9. PubMed ID: 22633835
[TBL] [Abstract][Full Text] [Related]
8. Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes.
Ciplea AI; Langer-Gould A; Stahl A; Thiel S; Queisser-Wahrendorf A; Gold R; Hellwig K
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32434802
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: management issues during pregnancy.
Ferrero S; Pretta S; Ragni N
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy in multiple sclerosis.
Hellwig K
Eur Neurol; 2014; 72 Suppl 1():39-42. PubMed ID: 25278125
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multiple sclerosis during pregnancy - safety considerations.
Thöne J; Thiel S; Gold R; Hellwig K
Expert Opin Drug Saf; 2017 May; 16(5):523-534. PubMed ID: 28333552
[TBL] [Abstract][Full Text] [Related]
12. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
MacDonald SC; McElrath TF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in the Setting of Multiple Sclerosis.
Fabian M
Continuum (Minneap Minn); 2016 Jun; 22(3):837-50. PubMed ID: 27261685
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.
Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelzstejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Siquineli F; Tosta ED
CNS Drugs; 2013 Nov; 27(11):955-61. PubMed ID: 24114585
[TBL] [Abstract][Full Text] [Related]
15. Reproductive Issues in MS.
Houtchens MK; Kaplan TB
Semin Neurol; 2017 Dec; 37(6):632-642. PubMed ID: 29270936
[TBL] [Abstract][Full Text] [Related]
16. MRI activity in MS and completed pregnancy: Data from a tertiary academic center.
Houtchens M; Bove R; Healy B; Houtchens S; Kaplan TB; Mahlanza T; Chitnis T; Bakshi R
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32917773
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Cuello JP; Martínez Ginés ML; Martin Barriga ML; de Andrés C
Neurologia; 2017 Mar; 32(2):92-98. PubMed ID: 25728948
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.
Bsteh G; Algrang L; Hegen H; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2020 Jan; 26(1):69-78. PubMed ID: 30507345
[TBL] [Abstract][Full Text] [Related]
19. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.
Amato MP; Portaccio E
CNS Drugs; 2015 Mar; 29(3):207-20. PubMed ID: 25773609
[TBL] [Abstract][Full Text] [Related]
20. [Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
Hanulíková P; Vlk R; Meluzínová E; Hynčicová E; Binder T; Chmel R; Rob L
Ceska Gynekol; 2013 Apr; 78(2):142-8. PubMed ID: 23710978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
